Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target

被引：0
|
作者：
Sanne Bootsma
Sanne M. van Neerven
Louis Vermeulen
机构：
[1] Amsterdam University Medical Centers,Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism
[2] Oncode Institute Amsterdam,undefined
来源：
Nature Genetics | 2021年 / 53卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Half of all colorectal cancers bear KRAS-activating mutations that affect the metabolic dependencies of cancer cells and drive resistance to commonly used drugs. A new study provides insights into KRAS-driven metabolic rewiring and identifies a new therapeutic target for KRAS-mutant cancers.
引用
收藏
页码：9 / 10
页数：1
相关论文
共 50 条
  • [1] Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target
    Bootsma, Sanne
    van Neerven, Sanne M.
    Vermeulen, Louis
    NATURE GENETICS, 2021, 53 (01) : 9 - 10
  • [2] Chemoproteomics provide insights into cell surface reprogramming during KRAS-mediated transformation
    Nandagopal, Neethi
    Aubert, Leo
    Nourreddine, Sami
    Lavoie, Genevieve
    Roux, Philippe
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Oncogenic KRAS-mediated epigenetic reprogramming is altered by loss of Activating Transcription Factor 3
    Mousavi, Fatemeh
    Pin, Christopher L.
    Shooshtari, Parisa
    CANCER RESEARCH, 2024, 84 (17)
  • [4] Characterization of Kras-mediated pancreatic tumorigenesis in zebrafish
    Davison, Jon M.
    Park, Seung Woo
    Rhee, Jerry M.
    Leach, Steven D.
    SMALL GTPASES IN DISEASE, PART A, 2008, 438 : 391 - 417
  • [5] KRAS-mediated therapeutic resistance abrogates immunogenic cell death in colorectal cancer cells
    Wang, Yi-Jun
    Chen, Dongshi
    Tong, Jingshan
    Yu, Jian
    Bardelli, Alberto
    Zhang, Lin
    CANCER RESEARCH, 2017, 77
  • [6] KRAS-mediated epigenetic reprogramming upregulates RELB-dependent CXCR2 expression to promote transformation
    Durand, Joel
    Baldwin, Albert
    CANCER RESEARCH, 2015, 75
  • [7] AMPKα loss promotes KRAS-mediated lung tumorigenesis
    Manuela La Montagna
    Lei Shi
    Peter Magee
    Sudhakar Sahoo
    Matteo Fassan
    Michela Garofalo
    Cell Death & Differentiation, 2021, 28 : 2673 - 2689
  • [8] Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
    Kerr, Emma M.
    Gaude, Edoardo
    Turrell, Frances K.
    Frezza, Christian
    Martins, Carla P.
    NATURE, 2016, 531 (7592) : 110 - +
  • [9] Akt Activation Is Important In KRAS-Mediated Multistep Leukemogenesis
    Ward, Ashley F.
    Shieh, Angell
    Harding-Theobald, Emily Rose
    Bollag, Gideon
    Shannon, Kevin
    BLOOD, 2010, 116 (21) : 1707 - 1707
  • [10] Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
    Liu, Xinquan
    Ghosh, Debadyuti
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 6589 - 6600
12345